The dual GLP-1R and GIP receptor (GIPR) agonist treatment induced better glycaemic control and body weight reduction in diet-induced obesity (DIO) mice compared with liraglutide (GLP-1R agonist)-only-treated controls100. The gene discussed is GLP1R; the disease is obesity due to melanocortin 4 receptor deficiency.